Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 3331 AL 3345

The role of the sub-thalamic nucleus in the preparation of volitional movement termination in Parkinson's disease

Hsu YT, Lai HY, Chang YC, Chiou SM, Lu MK, Lin YC, Liu YL, Chen CC, Huang HC, Chien TF, Lin SZ, Chen YY, Tsai CH.

Exp Neurol. 2012 Jan;233(1):253-63. doi: 10.1016/j.expneurol.2011.10.013. Epub 2011 Oct 21.

Stem cell pathologies and neurological disease

Steindler DA, Okun MS, Scheffler B.

Mod Pathol. 2012 Feb;25(2):157-62. doi: 10.1038/modpathol.2011.165. Epub 2011 Nov 4.

Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisons

Haddad PM, Das A, Keyhani S, Chaudhry IB.

J Psychopharmacol. 2012 May;26(5 Suppl):15-26. doi: 10.1177/0269881111424929. Epub 2011 Nov 5.

Oil based nanocarrier system for transdermal delivery of ropinirole: a mechanistic, pharmacokinetic and biochemical investigation

Azeem A, Talegaonkar S, Negi LM, Ahmad FJ, Khar RK, Iqbal Z.

Int J Pharm. 2012 Jan 17;422(1-2):436-44. doi: 10.1016/j.ijpharm.2011.10.039. Epub 2011 Oct 25.

Laryngeal dystonia in the course of multiple system atrophy: a cause of postoperative respiratory insufficiency

Wujtewicz MA, Chwojnicki K, Owczuk R, Wujtewicz M.

Neurol Sci. 2012 Jun;33(3):681-3. doi: 10.1007/s10072-011-0840-9. Epub 2011 Nov 6.

Heatstroke in patients with Parkinson's disease

Yamashita S, Uchida Y, Kojima S, Sakaguchi H, Kimura E, Maeda Y, Uchino M.

Neurol Sci. 2012 Jun;33(3):685-7. doi: 10.1007/s10072-011-0842-7. Epub 2011 Nov 6.

Zoophilia and impulse control disorder in a patient with Parkinson disease

Raina G, Cersosimo MG, Micheli F.

J Neurol. 2012 May;259(5):969-70. doi: 10.1007/s00415-011-6270-z. Epub 2011 Nov 5.

Parkin, PINK1 and mitochondrial integrity: emerging concepts of mitochondrial dysfunction in Parkinson's disease

Pilsl A, Winklhofer KF.

Acta Neuropathol. 2012 Feb;123(2):173-88. doi: 10.1007/s00401-011-0902-3. Epub 2011 Nov 6.

Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study

Esposito E, Mariani P, Ravani L, Contado C, Volta M, Bido S, Drechsler M, Mazzoni S, Menegatti E, Morari M, Cortesi R.

Eur J Pharm Biopharm. 2012 Feb;80(2):306-14. doi: 10.1016/j.ejpb.2011.10.015. Epub 2011 Oct 28.

Migraine- and dystonia-related disease-mutations of Na+/K+-ATPases: relevance of behavioral studies in mice to disease symptoms and neurological manifestations in humans

Bøttger P, Doğanlı C, Lykke-Hartmann K.

Neurosci Biobehav Rev. 2012 Feb;36(2):855-71. doi: 10.1016/j.neubiorev.2011.10.005. Epub 2011 Nov 2.

Patient diaries as a clinical endpoint in Parkinson's disease clinical trials

Papapetropoulos SS.

CNS Neurosci Ther. 2012 May;18(5):380-7. doi: 10.1111/j.1755-5949.2011.00253.x. Epub 2011 Jun 7.

Stem cell challenges in the treatment of neurodegenerative disease

Feng Z, Gao F.

CNS Neurosci Ther. 2012 Feb;18(2):142-8. doi: 10.1111/j.1755-5949.2011.00239.x. Epub 2011 Feb 26.

Sudden death associated with danon disease in women

Miani D, Taylor M, Mestroni L, D'Aurizio F, Finato N, Fanin M, Brigido S, Proclemer A.

Am J Cardiol. 2012 Feb 1;109(3):406-11. doi: 10.1016/j.amjcard.2011.09.024. Epub 2011 Nov 9.

Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease

Sgambato-Faure V, Cenci MA.

Prog Neurobiol. 2012 Jan;96(1):69-86. doi: 10.1016/j.pneurobio.2011.10.005. Epub 2011 Nov 3.

Using imaging to identify psychogenic parkinsonism before deep brain stimulation surgery. Report of 2 cases

Pourfar MH, Tang CC, Mogilner AY, Dhawan V, Eidelberg D.

J Neurosurg. 2012 Jan;116(1):114-8. doi: 10.3171/2011.10.JNS11554. Epub 2011 Nov 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias